循环miRNA作为肺癌诊断和预后无创标志物的研究进展(5)
[22] Shi GL，Chen Y，Sun Y，et al. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer [J]. Clin Lab，2017，63(1)：133-140.
[23] Sun Y，Mei H，Xu C，et al. Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma [J]. Pathol Res Pract，2018，214(1)：119-125.
[24] Sromek M，Glogowski M，Chechlinska M，et al. Changes in plasma miR-9，miR-16，miR-205 and miR-486 levels after non-small cell lung cancer resection [J]. Cell Oncol (Dordr)，2017，40(5)：529-536.
[25] Halvorsen AR，Bjaan？覸s M，LeBlanc M，et al. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer [J]. Oncotarget，2016，7(24)：37250-37259.
[26] Tang D，Shen Y，Wang M，et al. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer [J]. Eur J Cancer Prev，2013，22(6)：540-548.
[27] Su K，Zhang T，Wang Y，et al. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer [J]. World J Surg Oncol，2016，14(1)：224-229.
[28] Xu X，Zhu S，Tao Z，et al. High circulating miR-18a，miR-20a，and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer [J]. Cancer Med，2018，7(1)：21-31.
[29] Sun B，Liu HF，Ding Y，et al. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer [J]. Eur Rev Med Pharmacol Sci，2018， 22(10)：3061-3066.
(收稿日期：2020-01-22 本文編辑：封 华), 百拇医药(杜歆玥 杨慧龄)
[23] Sun Y，Mei H，Xu C，et al. Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma [J]. Pathol Res Pract，2018，214(1)：119-125.
[24] Sromek M，Glogowski M，Chechlinska M，et al. Changes in plasma miR-9，miR-16，miR-205 and miR-486 levels after non-small cell lung cancer resection [J]. Cell Oncol (Dordr)，2017，40(5)：529-536.
[25] Halvorsen AR，Bjaan？覸s M，LeBlanc M，et al. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer [J]. Oncotarget，2016，7(24)：37250-37259.
[26] Tang D，Shen Y，Wang M，et al. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer [J]. Eur J Cancer Prev，2013，22(6)：540-548.
[27] Su K，Zhang T，Wang Y，et al. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer [J]. World J Surg Oncol，2016，14(1)：224-229.
[28] Xu X，Zhu S，Tao Z，et al. High circulating miR-18a，miR-20a，and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer [J]. Cancer Med，2018，7(1)：21-31.
[29] Sun B，Liu HF，Ding Y，et al. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer [J]. Eur Rev Med Pharmacol Sci，2018， 22(10)：3061-3066.
(收稿日期：2020-01-22 本文編辑：封 华), 百拇医药(杜歆玥 杨慧龄)